We are shaping Parkinson’s research by delivering pre-clinical science and clinical trials that have the potential to provide drugs and other treatments that slow, stop or reverse Parkinson’s.

Much of our drive is focused on the repurposing of existing drugs, the acceleration of new pharmacological agents, and the development of regenerative therapies. Through our leading International Linked Clinical Trials (iLCT) programme, we are screening and prioritising therapies to be clinically tested, in order to bring new treatments to the clinic as soon as possible for the Parkinson’s community. Once a drug is selected, we work with an international network of hospitals to set up and conduct clinical trials.

Our International Linked Clinical Trials programme (iLCT)

Our iLCT programme screens multiple prospective new treatments for Parkinson’s.

Find out more

Preclinically, our independent research committee only considers research that is within five years of clinical testing. The research committee interrogates new proposals and analyses research reports from the trials we are funding to ensure that the science is robust, progress effective and results disseminated rapidly. We encourage collaboration between scientists, scientists and patients, and funders and foster these relationships to accelerate progress and ultimately benefit people living with Parkinson’s.

The science behind Parkinson’s

Our understanding of Parkinson’s is increasing all the time. Every month, more scientific findings add to the evidence, and take us one step closer to a cure.

Find out more
Our pre-clinical research

Before an experimental therapy can be tested in humans, there needs to be evidence that it works in Parkinson’s. This data helps provide a case for support in taking the treatment forward into clinical testing. Cure Parkinson’s is an international funder of pre-clinical research.

Find out more
Our priority projects

Our goal for the next five years is to ensure we can commit more therapies to trial to create new, effective treatments that affect disease progression for people living with Parkinson’s.

Find out more

If you are a researcher, find out more about our research programme and how you can work with us.

Find out Mmre

Curing Parkinson’s

What does a cure for Parkinson’s look like and what are we doing to achieve this?

Find out more